EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

[Translated article] Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care

Andrea Rodríguez Esquíroz, Amaya Echeverría Gorriti, Marta Marín Marín, Lorea Sanz Álvarez, Patricia García González, Javier Gorricho Mendivil, Juan Úriz Otano, Javier Garjón Parra, Inés Aguinaga Ontoso

Farmacia Hospitalaria · 2026-11 · 50 (6) · T381-T387

DOI: 10.1016/j.farma.2026.07.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Farmacia Hospitalaria, 2026-11. Verfasst von Andrea Rodríguez Esquíroz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Subdirección de Farmacia y Prestaciones, Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (Idi…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The presence of cirrhosis may require adjustment of medication doses or substitution with safer alternatives. Inadequate treatment can lead to medication-related problems, which in most cases are preventable. The objectives are to describe the implementation of a safety strategy consisting of a comprehensive medication review for patients with cirrhosis, and to evaluate the acceptance rate of the intervention. METHODS: It is a study of the implementation of a medication risk minimization strategy. It consisted of a medication review by hospital pharmacists, with clinical advice from a physician specializing in hepatology to patients in Primary Care. RESULTS: A total of 307 patients were included in the study, of whom 76.2% had at least one potentially inappropriate medication prescribed, for with a safer alternative was available in 87.2% of cases. Benzodiazepines and related drugs, proton pump inhibitors, and lipid-lowering drugs were the most frequently proposed. Benzodiazepines and related drugs were the least modified by physicians. 48.1% of the 405 proposals were accepted. CONCLUSIONS: A high percentage of patients with cirrhosis were receiving inadequate treatment for their hepatic pathology, despite the availability of alternatives to minimize risks in most cases. Half of the pharmacists' recommendations were accepted and the acceptance rate of these proposals was not influenced by patient characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisDrug-Related Side Effects and Adverse ReactionsHumansPrimary Health CareFemaleMaleAgedMiddle AgedInappropriate PrescribingPharmacists

Stichwörter der Autor:innen

Cirrosis hepáticaFarmacéuticoLiver cirrhosisMedication reviewPharmacistsRevisión de tratamientoSafetySeguridad

Autor:innen und Institutionen

  • Subdirección de Farmacia y Prestaciones, Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain. Electronic address: arodries@navarra.es.
  • Subdirección de Farmacia y Prestaciones, Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
  • Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain; Servicio de Farmacia, Hospital García Orcoyen, Servicio Navarro de Salud-Osasunbidea, Estella, Spain.
  • Servicio de Digestivo, Unidad de Hepatología, Hospital Universitario de Navarra, Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain.
  • Departamento de Ciencias de la Salud, Universidad Pública de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA) CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Pamplona, Nav…

Zitieren

APA

Rodríguez Esquíroz, A., Echeverría Gorriti, A., Marín Marín, M., Sanz Álvarez, L., García González, P., Gorricho Mendivil, J., Úriz Otano, J., Garjón Parra, J., & Aguinaga Ontoso, I. (2026). [Translated article] Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care. Farmacia Hospitalaria, 50(6), T381-T387. https://doi.org/10.1016/j.farma.2026.07.010

Vancouver

Rodríguez Esquíroz A, Echeverría Gorriti A, Marín Marín M, Sanz Álvarez L, García González P, Gorricho Mendivil J, et al. [Translated article] Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care. Farmacia Hospitalaria. 2026;50(6):T381-T387. doi:10.1016/j.farma.2026.07.010

BibTeX
@article{RodrguezEsquroz2026,
  author = {Rodríguez Esquíroz, Andrea and Echeverría Gorriti, Amaya and Marín Marín, Marta and Sanz Álvarez, Lorea and García González, Patricia and Gorricho Mendivil, Javier and Úriz Otano, Juan and Garjón Parra, Javier and Aguinaga Ontoso, Inés},
  title = {[Translated article] Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care},
  journal = {Farmacia Hospitalaria},
  year = {2026},
  volume = {50},
  number = {6},
  pages = {T381--T387},
  doi = {10.1016/j.farma.2026.07.010}
}
Kostenlos starten →